Skip to main content

Table 1 Baseline plasma glucose and insulin concentrations

From: Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance

Group

Blood glucose (mg/dL)

Plasma insulin (ng/ml)

NO Donor vs. Saline

WT + SAL

104 ± 8

1.3 ± 0.4

WT + NO

101 ± 9

0.3 ± 0.1*

LPS vs. Saline; iNOS−/− vs. iNOS+/+ Mice

WT + SAL

96 ± 5

0.7 ± 0.2

WT + LPS

88 ± 6

0.7 ± 0.2

iNOS KO + SAL

96 ± 5

1.0 ± 0.1

iNOS KO + LPS

83 ± 6**

0.7 ± 0.3

  1. All blood and plasma measurements were sampled 10 min before clamp onset (i.e., t = −10 min). Data are presented as mean ± SEM. *p < 0.05 vs. WT + SAL; **p < 0.05 vs. iNOS KO + SAL. iNOS inducible nitric oxide synthase, KO knock-out, LPS lipopolysaccharide, NO nitric oxide donor (sodium nitroprusside), SAL saline, WT wild-type